ABSTRACT
Polymer-graphene composites have attracted significant attention; however, their formation mechanisms are a focus of debate. This work tries to clarify how grafting occurs on graphene by electron spin resonance techniques. As a result, two pathways are found. One passes through the radicals formed by cleaving CO bonds on graphene are transferred to monomers, then grafting and polymerization proceed. Another mechanism passes through the oxy-radicals, which react with monomers in solution and finally react with carbon radicals on graphene. Based on the mechanism, various types of polymer-graphene composites are prepared, and applied to electrical conductive sheets, basic catalysts, and acidic catalysts.
Subject(s)
Graphite , Electric Conductivity , Macromolecular Substances , Polymerization , PolymersABSTRACT
Risk classification and clinical management of the DNA variant of unknown significance(VUS)in BRCA 1/2 remains unestablished. The Japanese hereditary breast and ovarian cancer(HBOC)consortium and myriad genetics reported that the VUS rate of BRCA is 6.5% in Japanese patients, but is <2% in the USA. The types of mutation supposedly differ between Asian and European ethnicities. Breast-conserving therapy(BCT)is not recommended in HBOC breast cancer, according to the 2017 Japanese guidelines by the Ministry of Health, because of the risk of ipsilateral breast recurrence(IBR)and carcinogenesis by radiation. In our hospital, we recommend an initial mastectomy and breast reconstruction with an implant for patients with HBOC breast cancer, considering future surgery on the contralateral side and symmetry of the reconstructed breast. However, the risk of IBR after BCT is not significantly high in patients with HBOC breast cancer, and BCT is a reasonable option even for definite HBOC breast cancer under low risk conditions. Hence, BCT is feasible for treating breast cancer in carriers of VUS following decision-making and informed consent from the patients.
